SPRY Financial Statements

Balance sheet, income statement, cash flow, and dividends for Ars Pharmaceuticals Inc (SPRY).


$1.03B Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

SPRY Market Cap. (MRY)


SPRY Shares Outstanding (MRY)


SPRY Assets (MRY)


Total Assets

$351.15M

Total Liabilities

$94.36M

Total Investments

$263.20M

SPRY Income (MRY)


Revenue

$89.15M

Net Income

$8.00M

Operating Expense

$91.25M

SPRY Cash Flow (MRY)


CF Operations

$13.55M

CF Investing

-$106.10M

CF Financing

$72.40M

SPRY Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SPRY Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$351,153,000 (50.59%)

$233,188,000 (-17.14%)

$281,435,000 (358.02%)

$61,446,000 (-84.44%)

Assets Current

$334,295,000 (44.26%)

$231,726,000 (-16.56%)

$277,700,000 (357.27%)

$60,730,000 (-84.45%)

Assets Non-Current

$16,858,000 (1053.08%)

$1,462,000 (-60.86%)

$3,735,000 (421.65%)

$716,000 (-82.74%)

Goodwill & Intangible Assets

$7,371,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$256,798,000 (11.28%)

$230,760,000 (-15.44%)

$272,886,000 (972.70%)

-$31,269,000 (-108.17%)

Property Plant & Equipment Net

$1,066,000 (29.37%)

$824,000 (6.46%)

$774,000 (11.69%)

$693,000 (-81.75%)

Cash & Equivalents

$50,817,000 (-28.40%)

$70,971,000 (-66.29%)

$210,518,000 (250.50%)

$60,063,000 (-84.48%)

Accumulated Other Comprehensive Income

$220,000 (348.98%)

$49,000 (-87.96%)

$407,000 (0%)

$0 (0%)

Deferred Revenue

$557,000 (0%)

$0 (0%)

$283,000 (-80.58%)

$1,457,000 (0%)

Total Investments

$263,205,000 (67.23%)

$157,389,000 (146.45%)

$63,863,000 (0%)

$0 (0%)

Investments Current

$263,205,000 (67.23%)

$157,389,000 (146.45%)

$63,863,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$10,519,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$8,175,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$22,841,000 (960.40%)

$2,154,000 (-56.32%)

$4,931,000 (58.71%)

$3,107,000 (20.29%)

Accumulated Retained Earnings (Deficit)

-$123,305,000 (6.09%)

-$131,303,000 (-70.66%)

-$76,938,000 (-82.08%)

-$42,256,000 (56.32%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$69,425,000 (25237.59%)

$274,000 (-43.04%)

$481,000 (-94.68%)

$9,033,000 (122.16%)

Debt Current

$42,000 (-82.28%)

$237,000 (3.04%)

$230,000 (-93.65%)

$3,623,000 (108.22%)

Debt Non-Current

$69,383,000 (187421.62%)

$37,000 (-85.26%)

$251,000 (-95.36%)

$5,410,000 (132.59%)

Total Liabilities

$94,355,000 (3786.12%)

$2,428,000 (-71.60%)

$8,549,000 (-48.73%)

$16,676,000 (39.82%)

Liabilities Current

$23,440,000 (880.34%)

$2,391,000 (-56.08%)

$5,444,000 (-33.50%)

$8,187,000 (-14.73%)

Liabilities Non-Current

$70,915,000 (191562.16%)

$37,000 (-98.81%)

$3,105,000 (-63.42%)

$8,489,000 (264.96%)

SPRY Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$89,149,000 (297063.33%)

$30,000 (-97.72%)

$1,316,000 (-76.10%)

$5,506,000 (0%)

Cost of Revenue

$977,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$71,675,000 (51.58%)

$47,284,000 (156.20%)

$18,456,000 (293.77%)

$4,687,000 (-43.81%)

Research & Development Expense

$19,580,000 (-3.38%)

$20,266,000 (10.29%)

$18,376,000 (-9.36%)

$20,273,000 (-17.51%)

Operating Expenses

$91,255,000 (35.09%)

$67,550,000 (83.40%)

$36,832,000 (47.56%)

$24,960,000 (-24.18%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$288,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$7,998,000 (114.71%)

-$54,365,000 (-56.75%)

-$34,682,000 (-71.33%)

-$20,243,000 (38.56%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$7,998,000 (114.71%)

-$54,365,000 (-56.75%)

-$34,682,000 (-71.33%)

-$20,243,000 (38.56%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$7,998,000 (114.71%)

-$54,365,000 (-56.75%)

-$34,682,000 (-71.33%)

-$20,243,000 (38.56%)

Weighted Average Shares

$96,936,661 (1.81%)

$95,215,322 (138.30%)

$39,956,043 (38.39%)

$28,872,242 (893.01%)

Weighted Average Shares Diluted

$102,390,828 (7.54%)

$95,215,322 (138.30%)

$39,956,043 (38.39%)

$28,872,242 (893.01%)

Earning Before Interest & Taxes (EBIT)

$8,286,000 (115.24%)

-$54,365,000 (-56.75%)

-$34,682,000 (-71.33%)

-$20,243,000 (38.50%)

Gross Profit

$88,172,000 (293806.67%)

$30,000 (-97.72%)

$1,316,000 (-76.10%)

$5,506,000 (0%)

Operating Income

-$3,083,000 (95.43%)

-$67,520,000 (-90.11%)

-$35,516,000 (-82.56%)

-$19,454,000 (40.90%)

SPRY Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$106,101,000 (-21.70%)

-$87,180,000 (-43709.05%)

-$199,000 (-261.82%)

-$55,000 (94.00%)

Net Cash Flow from Financing

$72,399,000 (949.41%)

$6,899,000 (-96.38%)

$190,732,000 (258.80%)

$53,158,000 (-86.99%)

Net Cash Flow from Operations

$13,548,000 (122.86%)

-$59,266,000 (-47.88%)

-$40,078,000 (-128.22%)

-$17,561,000 (43.71%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$20,154,000 (85.56%)

-$139,547,000 (-192.75%)

$150,455,000 (323.32%)

$35,542,000 (-90.56%)

Net Cash Flow - Business Acquisitions and Disposals

-$7,500,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$98,038,000 (-12.68%)

-$87,005,000 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$563,000 (-221.71%)

-$175,000 (12.06%)

-$199,000 (-261.82%)

-$55,000 (94.00%)

Issuance (Repayment) of Debt Securities

$69,383,000 (0%)

$0 (0%)

-$8,681,000 (-377.77%)

-$1,817,000 (-159.57%)

Issuance (Purchase) of Equity Shares

$3,016,000 (-56.28%)

$6,899,000 (1110.35%)

$570,000 (237.28%)

$169,000 (-99.93%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$14,534,000 (57.38%)

$9,235,000 (58.05%)

$5,843,000 (106.54%)

$2,829,000 (7.16%)

Depreciation Amortization & Accretion

$79,000 (8.22%)

$73,000 (-77.12%)

$319,000 (49.77%)

$213,000 (-87.54%)

SPRY Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

98.90% (-1.10%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

9.00% (100.00%)

-181216.70% (-6776.25%)

-2635.40% (-616.73%)

-367.70%

EBITDA Margin

9.40% (100.01%)

-180973.30% (-6830.66%)

-2611.20% (-617.76%)

-363.80%

Return on Average Equity (ROAE)

3.60% (116.22%)

-22.20% (-77.60%)

-12.50% (-58.23%)

-7.90% (61.08%)

Return on Average Assets (ROAA)

3.10% (114.42%)

-21.50% (-79.17%)

-12.00% (-71.43%)

-7.00% (56.52%)

Return on Sales (ROS)

9.30% (100.01%)

-181216.70% (-6776.25%)

-2635.40% (-616.73%)

-367.70%

Return on Invested Capital (ROIC)

3.90% (111.50%)

-33.90% (34.56%)

-51.80% (75.53%)

-211.70% (83.39%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

131.88 (1471.70%)

-9.61 (1.95%)

-9.8 (-3.06%)

-9.51 (-132.62%)

Price to Sales Ratio (P/S)

11.47 (-99.93%)

17,392.41 (6615.58%)

258.99 (641.57%)

34.92

Price to Book Ratio (P/B)

3.99 (75.13%)

2.28 (102.31%)

1.13 (115.08%)

-7.47 (-316.49%)

Debt to Equity Ratio (D/E)

0.37 (3236.36%)

0.01 (-64.52%)

0.03 (105.82%)

-0.53 (-1819.35%)

Earnings Per Share (EPS)

0.08 (114.04%)

-0.57 (34.48%)

-0.87 (-24.29%)

-0.7 (93.82%)

Sales Per Share (SPS)

0.92 (0%)

0 (0%)

0.03 (-82.72%)

0.19 (0%)

Free Cash Flow Per Share (FCFPS)

0.13 (121.47%)

-0.62 (38.10%)

-1.01 (-65.25%)

-0.61 (94.48%)

Book Value Per Share (BVPS)

2.65 (9.28%)

2.42 (-64.51%)

6.83 (730.66%)

-1.08 (-100.82%)

Tangible Assets Book Value Per Share (TABVPS)

3.55 (44.79%)

2.45 (-65.23%)

7.04 (231.02%)

2.13 (-98.43%)

Enterprise Value Over EBIT (EV/EBIT)

119 (1422.22%)

-9 (-200.00%)

-3 (-200.00%)

3 (108.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

117.84 (1473.29%)

-8.58 (-182.64%)

-3.04 (-199.31%)

3.06 (108.06%)

Asset Turnover

0.35 (0%)

0 (0%)

0.01 (-73.68%)

0.02 (0%)

Current Ratio

14.26 (-85.28%)

96.92 (89.99%)

51.01 (587.65%)

7.42 (-81.77%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$12,985,000 (121.85%)

-$59,441,000 (-47.58%)

-$40,277,000 (-128.64%)

-$17,616,000 (45.14%)

Enterprise Value (EV)

$985,751,761 (111.60%)

$465,859,941 (346.57%)

$104,318,623 (270.36%)

-$61,233,287 (-105.18%)

Earnings Before Tax (EBT)

$8,286,000 (115.24%)

-$54,365,000 (-56.75%)

-$34,682,000 (-71.33%)

-$20,243,000 (38.56%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$8,365,000 (115.41%)

-$54,292,000 (-58.00%)

-$34,363,000 (-71.56%)

-$20,030,000 (35.82%)

Invested Capital

$338,950,000 (111.71%)

$160,100,000 (142.74%)

$65,954,000 (2858.91%)

$2,229,000 (-5.15%)

Working Capital

$310,855,000 (35.55%)

$229,335,000 (-15.76%)

$272,256,000 (418.16%)

$52,543,000 (-86.21%)

Tangible Asset Value

$343,782,000 (47.43%)

$233,188,000 (-17.14%)

$281,435,000 (358.02%)

$61,446,000 (-84.44%)

Market Capitalization

$1,025,306,761 (94.90%)

$526,064,941 (71.03%)

$307,577,623 (31.66%)

$233,606,713 (-82.32%)

Average Equity

$224,221,250 (-8.27%)

$244,437,750 (-12.07%)

$277,995,250 (9.12%)

$254,766,000 (57.21%)

Average Assets

$254,575,750 (0.65%)

$252,922,000 (-12.71%)

$289,741,750 (-0.36%)

$290,795,500 (41.70%)

Invested Capital Average

$209,931,750 (30.95%)

$160,313,500 (139.63%)

$66,901,750 (599.55%)

$9,563,500 (270.32%)

Shares

97,185,475 (1.24%)

95,997,252 (166.23%)

36,058,338 (2.80%)

35,076,083 (23.00%)